CSS
UTHR icon

Cubist Systematic Strategies’s United Therapeutics UTHR Stock Holding History

Cubist Systematic Strategies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,900
Closed -$1.11M – 4143
2023
Q3 		$1.11M Buy
4,900
+1,000
+26% +$230K 0.01% 1817
2023
Q2 		$861K Hold
3,900
– – 0.01% 2050
2023
Q1 		$873K Buy
+3,900
New +$961K 0.01% 2278

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Cubist Systematic Strategies's UTHR Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in United Therapeutics (UTHR) in Q3 2025: 10,371 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #1046 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in UTHR as recently as Q1 2024.

Cubist Systematic Strategies first reported a position in UTHR in Q2 2014 and has held it in 37 quarters since. The position peaked at $15.5M in Q4 2022. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Cubist Systematic Strategies held 10,371 shares of United Therapeutics worth $4.35M as of Q3 2025.
  • United Therapeutics was a new Cubist Systematic Strategies position in Q3 2025.
  • United Therapeutics made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1046 holding.
  • Cubist Systematic Strategies first reported a position in United Therapeutics in Q2 2014 and has held it in 37 quarters since.
  • Cubist Systematic Strategies's United Therapeutics position peaked at $15.5M in Q4 2022.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.